Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by ifsoon Aug 04, 2021 4:19pm
40 Views
Post# 33649737

RE:Why we are all here...;) $ <==

RE:Why we are all here...;) $ <==Come on Newcamo. You can't even give credit to Dumyjones for that incredible text! 
You're great at copy and paste as you prove it again, and again, and again, and again ad nauseam...,but lack complete imagination.
My guess: You can't give credit to Dumyjones as giving credit to yourself
would look stupid. (In case you don't know, you already look stupid. (
Newcamo wrote:

100M$ cash voucher (non dilutive) on 90M$ market cap sp will 2x,3x easy... thats why these clowns want your shares. Now, when is it coming? See latest NR: the Rare Pediatric Disease Priority Review Voucher ("PRV") by its subsidiary, Prometic Biotherapeutics Inc. ("PBT"), which would be payable to Liminal prior to closing the divestment of its remaining plasma-derived therapeutics business operated through PBT (the "Second Closing").

 

coming anytime...

-----------------------------------------------------------------------------------------------------------------

everybody on this board and the market manipulators want your shares... this stock wil ride high next days... 

With this FDA ok, we can sell that riplazym voucher...market price is between 80M$-120M$ u.s., so lets say 100M$ u.s., we get 70%.... 70M$ u.s. + 17M$ u.s. we cashed already, around 100M$ can$ , lmnl will be able to execute big time and do more deals like this (sell or partner), we gat some in the oven already. Doyour dd. Dont listen to the clown$ operating on this board.  They are here for $$$... accumulation time....




<< Previous
Bullboard Posts
Next >>